Protein biomarkers of alcohol abuse

Expert Rev Proteomics. 2012 Aug;9(4):425-36. doi: 10.1586/epr.12.38.

Abstract

Alcohol abuse can lead to a number of health and social issues. Our current inability to accurately assess long-term drinking behaviors is an important obstacle to its diagnosis and treatment. Biomarkers for chronic alcohol consumption have made a number of important advances but have yet to become highly accurate and as accepted as objective tests for other diseases. Thus, there is a crucial need for the development of more sensitive and specific markers of alcohol abuse. Recent advancements in proteomic technologies have greatly increased the potential for alcohol abuse biomarker discovery. Here, the authors review established and novel protein biomarkers for long-term alcohol consumption and the proteomic technologies that have been used in their study.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Affinity Labels / chemistry
  • Alcohol Drinking / adverse effects*
  • Alcohol Drinking / blood
  • Alcohol-Induced Disorders / pathology
  • Alcoholism / diagnosis*
  • Alcoholism / metabolism
  • Biomarkers / blood*
  • Clusterin / blood
  • Cytokines / blood
  • Glycerophospholipids / blood
  • Humans
  • Proteome / analysis*
  • Proteomics / methods
  • Sensitivity and Specificity
  • Time Factors
  • Transferrin / chemistry

Substances

  • Affinity Labels
  • Biomarkers
  • CLU protein, human
  • Clusterin
  • Cytokines
  • Glycerophospholipids
  • Proteome
  • Transferrin
  • phosphatidylethanol